In this episode, we hear from Benjamin Alouf, Chief Medical Officer at Limbix. In their own words, Limbix is the first digital therapeutic for adolescent depression.
In this episode, we cover:
- Origin of the company and story behind the name ‘Limbix’
- The funding journey and key milestones achieved
- The choice to focus on the young adult population in particular
- Patient experience with SparkRx
- Defining good patient engagement in adolescent mental health
- Evidence generation and FDA submission process
- Business hypthothesis and scaling plan
- The future of the PDT market
Guest Links and Resources:
- Connect with Benjamin Alouf on LinkedIn
- Visit Limbix.com
Host Links:
- Connect with Eugene Borukhovich: Twitter | LinkedIn
- Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
- Connect with YourCoach.health: Website | Twitter
- Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
- HealthXL: Website | Twitter | Join an Event
Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
